Chris Cline, CNP, serves as the Urologic Oncology Champion at Central Ohio Urology Group. In this capacity, he leads a dedicated team of nurse navigators and advanced practice providers specializing in Advanced Prostate Cancer (APC). He manages a busy oncology clinic that serves nearly 500 APC patients and also operates an Androgen Deprivation Clinic to support the treatment of localized prostate cancer patients.
Recognized as an industry thought leader, Chris represents Dendreon and Janssen Pharmaceuticals, offering education on advanced oncologic therapies. He is involved in advisory boards and presents at national cancer conferences. Moreover, he heads an Advanced Kidney Cancer clinic where he administers Keytruda. As a Bladder Cancer Champion, he has significant expertise in treating high-risk, non-muscle invasive and muscle-invasive bladder cancers. Chris contributes to the advancement of urologic oncology by participating in various clinical trials.